Showing 901-910 of 1211 results for "".
- ViGeneron Announces EMA Approval of Clinical Trial Application for VG901, a Gene Therapy to Treat RPhttps://modernod.com/news/vigeneron-announces-ema-approval-of-clinical-trial-application-for-vg901-a-gene-therapy-to-treat-retinitis-pigmentosa/2481784/ViGeneron announced that the European Medicines Agency (EMA) has approved the clinical trial application for VG901, a gene therapy to treat CNGA1-associated retinitis pigmentosa (RP). VG901 uses vgAAV, ViGeneron's proprietary adeno-associated virus (AAV) vector to deliver the CNGA1
- EyeCare Partners Expands Presence in Virginia with Two Acquisitionshttps://modernod.com/news/eyecare-partners-expands-presence-in-virginia-with-two-acquisitions/2480998/EyeCare Partners (ECP) announced it has entered into an agreement to partner with Commonwealth Eye Care Associates (CECA) and Retina Institute of Virginia (RIV). Financial terms of the deals were not disclosed. Through the partnership with Commonwealth Eye Care Associates, ECP
- Atsena Therapeutics Announces Presentations at ARVO and ASGCThttps://modernod.com/news/atsena-therapeutics-announces-presentations-at-arvo-and-asgct/2480825/Atsena Therapeutics announced that research on two of its next-generation adeno-associated virus (AAV) technologies will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting, and the American Society of Gene & Cell Therapy (ASGC
- Retina Consultants of America Continues Growth With Partnership in Kansas and Missourihttps://modernod.com/news/retina-consultants-of-america-continues-growth-with-partnership-in-kansas-and-missouri/2478935/Retina Consultants of America (RCA) announced it has added Retina Associates, P.A. of Kansas City, based in Kansas and Missouri, to its group of practices. Retina Associates, P.A. serves the greater Kansas City, Topeka, Sedalia, and surrounding areas. Terms of the deal were no
- Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code From the AMA for the Insertion of Intracanalicular Insertshttps://modernod.com/news/ocular-therapeutix-announces-receipt-of-a-permanent-category-i-cpt-code-from-the-ama-for-the-insertion-of-intracanalicular-inserts/2478492/Ocular Therapeutix announced that its application for the creation of a Category I Current Procedural Terminology (CPT) procedure code, presented at the October 2020 American Medical Association (AMA) CPT Editorial Panel meeting, has been granted. The Panel has accepted the addition of a permanen
- NORA Issues Response to Medical Groups' Joint Guidance of Vision Disorders Following a Concussionhttps://modernod.com/news/nora-response-to-medical-groups-joint-guidance-of-vision-disorders-following-a-concussion/2480978/Below is the response from the Neuro Optometric Rehabilitation Association (NORA) regarding the recent statement from various ophthalmic organizations i
- Pandemic Will Leave Children With Less Access to Eye Care, New Survey Showshttps://modernod.com/news/pandemic-will-leave-children-with-less-access-to-eye-care-new-survey-shows/2478227/A survey conducted by the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) shows that pediatric specialists are struggling to keep their practices viable in the wake of the shutdown. As a result, ch
- AMA Releases COVID-19 Volunteer Guide for Health Care Professionalshttps://modernod.com/news/ama-releases-covid-19-volunteer-guide-for-health-care-professionals/2477561/The American Medical Association (AMA) has released a guide that includes information for physicians and health care professionals who want to support communities severely impac
- Cholesterol-Lowering Drugs Tied to Reduced Glaucoma Riskhttps://modernod.com/news/cholesterol-lowering-drugs-tied-to-reduced-glaucoma-risk/2476570/High cholesterol is associated with an increased risk of developing glaucoma, but a new study suggests taking statins to lower cholesterol helps to reduce this risk, according to a Reuters
- SightGlass Vision Presents Clinical Trial Data From Novel Lenses to Control Myopiahttps://modernod.com/news/sightglass-vision-presents-clinical-trial-data-from-novel-lenses-to-control-myopia/2476541/SightGlass Vision announced that data assessing the tolerability of three iterations of its novel lenses designed to control nearsightedness in children were presented at the Association for Research in Vision and